MYCN and neoplasm: In contrast to MYCN gene amplification, the degree of expression of the MYCN gene in the tumor does not predict prognosis [43,44], but it has been previously shown that the MYCN product (MYCN) is a nuclear phosphoprotein, which can transcriptionally activate many genes, either directly (e.g., ID2) or indirectly [45].